Cic edizioni internazionali
Functional Neurology

Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias

Review, 205 - 215
doi: 10.11138/FNeur/2016.31.4.205
Tag this article
Abstract
Enhanced HTML Full text PDF
Neuroimaging, both with magnetic resonance imaging (MRI) and positron emission tomography (PET), has gained a pivotal role in the diagnosis of primary neurodegenerative diseases. These two techniques are used as biomarkers of both pathology and progression of Alzheimer’s disease (AD) and to differentiate AD from other neurodegenerative diseases.
MRI is able to identify structural changes including patterns of atrophy characterizing neurodegenerative diseases, and to distinguish these from other causes of cognitive impairment, e.g. infarcts, space-occupying lesions and hydrocephalus.
PET is widely used to identify regional patterns of glucose utilization, since distinct patterns of distribution of cerebral glucose metabolism are related to different subtypes of neurodegenerative dementia.
The use of PET in mild cognitive impairment, though controversial, is deemed helpful for predicting conversion to dementia and the dementia clinical subtype. Recently, new radiopharmaceuticals for the in vivo imaging of amyloid burden have been licensed and more tracers are being developed for the assessment of tauopathies and inflammatory processes, which may underlie the onset of the amyloid cascade.
At present, the cerebral amyloid burden, imaged with PET, may help to exclude the presence of AD as well as forecast its possible onset. Finally PET imaging may be particularly useful in ongoing clinical trials for the development of dementia treatments. In the near future, the use of the above methods, in accordance with specific guidelines, along with the use of effective treatments will likely lead to more timely and successful treatment of neurodegenerative dementias.

Vol. XXXIII (No. 2) 2018 April/June

  1. Shorter acute care hospital stay, longer stay in post-acute care facilities
    Formisano R., Contrada M., Aloisi M.
    doi: 10.11138/FNeur/2018.33.2.065
  2. Understanding the pathophysiology of hyperglycemia-associated chorea-ballism: a systematic review of positron emission tomography findings
    Gómez Ochoa S. A., Espín Chico B.B.
    doi: 10.11138/FNeur/2018.33.2.067
  3. A review of 500 patients with acute stroke admitted to the University Hospital of Saudi Arabia. Similarities and differences compared with the published literature
    Zafar A.
    doi: 10.11138/FNeur/2018.33.2.073
  4. Direction-specific cortical response immediately after moving tactile stimuli in female humans
    Hiraoka K., Kento Y., Kiya H., Nozaki Y., Hayashi T.
    doi: 10.11138/FNeur/2018.33.2.081
  5. Impact of epilepsy after severe brain injury on safe resumption of driving: two-year follow-up
    Saviola D., De Tanti A., Delsoldato S., Chiari M., Inzaghi M.G., Baldari F.
    doi: 10.11138/FNeur/2018.33.2.091
  6. Epidemiological and clinical characteristics of 492 patients in a vegetative state in 29 Italian rehabilitation units. What about outcome?
    Avesani R., Dambruoso F., Scandola M., Formisano R., De Tanti A., Ferro S., Smania N., Roncari L., Rossato E.
    doi: 10.11138/FNeur/2018.33.2.097
  7. Laterality in Parkinson’s disease may predict motor and visual imagery abilities
    Lo Monaco M.R., Laudisio A., Fusco D., Vetrano D.L., Ricciardi D., Delle Donne V., Proietti F., Zuccalà G., Silveri M.C.
    doi: 10.11138/FNeur/2018.33.2.105
  8. Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study
    Baricich A., Cosenza L., Sandrini G., Paolucci S., Morone G., Santamato A., Cinone N., Peri E., Picelli A., Invernizzi M., Ferriero G.
    doi: 10.11138/FNeur/2018.33.2.113
  9. Musculoskeletal impairment and functional limitations in a patient affected by mutation in the laminin a-5 gene
    Liguori S., de Sire A., Moretti A., Sodano L., Sampaolo S., Gimigliano F., Iolascon G.
    doi: 10.11138/FNeur/2018.33.2.117
Last Viewed articles: la lista degli ultimi x visitati.
  1. Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias
    Del Sole A., Malaspina S., Magenta Biasina A.
    doi: 10.11138/FNeur/2016.31.4.205
credits